Internal Medicine · Brooklyn, NY
NPI
1104156728
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
86 Saint Felix St Fl 9
Brooklyn, NY, 11217
Phone (718) 250-8692
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
480 services
Medicare patients, 2024
254
Average age 75
Drug cost, 2024
$5.3M
10,842 prescriptions
Company payments, 2025
$2,814
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cesar E Ayala-Rodriguez was code 99214 (office e&m - established), 96 times for 63 patients. In total Cesar E Ayala-Rodriguez billed 480 services in 34 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 96 | 63 | $107.00 | $10K |
| 99213 Office E&M - Established | Office | 88 | 65 | $79.69 | $7,013 |
| 93306 Echocardiography (TTE/TEE) | Facility | 53 | 52 | $57.14 | $3,028 |
| 99214 Office E&M - Established | Facility | 39 | 23 | $75.20 | $2,933 |
| 99232 Hospital E&M - Subsequent | Facility | 33 | 32 | $62.15 | $2,051 |
| 99213 Office E&M - Established | Facility | 26 | 14 | $56.15 | $1,460 |
| 99222 Hospital E&M - Initial | Facility | 26 | 26 | $107.36 | $2,791 |
By year: 2022 $66K for 862 services; 2023 $48K for 588 services; 2024 $38K for 480 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cesar E Ayala-Rodriguez prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 790 prescriptions and refills. In total Cesar E Ayala-Rodriguez wrote 10,842 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 790 | 1,380 | 211 | $884K |
| Atorvastatin Calcium Generic | 629 | 1,432 | 250 | $6,159 |
| Mounjaro Tirzepatide | 597 | 602 | 131 | $608K |
| Metoprolol Succinate Generic | 520 | 1,083 | 158 | $7,946 |
| Rosuvastatin Calcium Generic | 456 | 1,144 | 179 | $6,128 |
| Eliquis Apixaban | 382 | 641 | 114 | $359K |
| Ozempic Semaglutide | 369 | 428 | 90 | $384K |
| Jardiance Empagliflozin | 339 | 591 | 105 | $337K |
| Nifedipine Er Nifedipine | 305 | 763 | 124 | $6,771 |
| Trulicity Dulaglutide | 304 | 326 | 80 | $301K |
| Spironolactone Generic | 303 | 660 | 114 | $1,908 |
| Nebivolol Hcl Generic | 291 | 631 | 94 | $13K |
| Trazodone Hcl Generic | 290 | 370 | 71 | $828 |
| Farxiga Dapagliflozin Propanediol | 285 | 494 | 93 | $268K |
| Valsartan Generic | 281 | 638 | 99 | $8,277 |
Brand drugs: 4,156 claims; generic drugs: 6,670 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cesar E Ayala-Rodriguez $2,814 ($2,814 in general payments such as food, travel and fees) from 19 companies. The largest payer was Novartis Pharmaceuticals Corporation with $346.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 16 | $346 |
| Alnylam Pharmaceuticals Inc. ALNY | 11 | $306 |
| Boston Scientific Corporation BSX | 2 | $272 |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $249 |
| Novo Nordisk Inc NVO | 9 | $210 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $189 |
| BridgeBio Pharma, Inc. BBIO | 7 | $186 |
| Merck Sharp & Dohme LLC MRK | 6 | $147 |
| Xeris Pharmaceuticals, Inc. | 3 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.